Literature DB >> 11312032

Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders.

N Ozçelik1, A Koşar, D Soysal.   

Abstract

Ochratoxin A (OA) is a nephrotoxic fungal metabolite (mycotoxin) occurring in foodstuffs. The compound is causally associated with mycotoxin porcine nephropathy, a disease comparable with a human kidney disease called endemic nephropathy. In this paper OA levels in the human serum samples collected from healthy individuals and individuals suffering from different urinary disorders in Isparta-Turkey are presented. OA was measured in serum samples of 40 healthy people and a total of 93 patients with different kinds of urinary disorders. Four different kinds of urinary disorders were represented: chronic renal failure treated by hemodialysis (35), chronic renal failure treated by peritoneal dialysis (28), patients with bladder cancer (15), patients with renal stones (15). Analysis of OA in human blood samples was performed using an analytical method based on the measurement of fluorescence spectra. The mean concentration of OA in the healthy group was 0.4 +/- 0.28 ng/ml. The highest mean concentration was found in the group of patients treated by hemodialysis, 2.1+/- 1.2 ng/ml. The mean concentrations of the toxin in all patients groups were higher compared to the control group. Also, a significant difference was found between the mean concentrations of the groups of patients treated by dialysis (hemodialysis or peritoneal dialysis) and of the patients with renal stones or bladder cancer, only with the exception of the difference between peritoneal dialysis and renal stones group. No other significant differences were found when comparing the two groups. The findings indicate that OA may have a role in the human urinary pathology considered herein. A higher level of OA in dialysis groups compared to the control, renal stones and bladder cancer groups could probably be explained by the reduced glomerular filtration rate of these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312032     DOI: 10.1016/s0378-4274(00)00291-5

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  15 in total

1.  The effects of season and gender on the serum aflatoxins and ochratoxin A levels of healthy adult subjects from the Central Anatolia Region, Turkey.

Authors:  Suna Sabuncuoglu; Pinar Erkekoglu; Sevtap Aydin; Gönül Şahin; Belma Kocer-Gumusel
Journal:  Eur J Nutr       Date:  2014-07-25       Impact factor: 5.614

2.  A preliminary assessment of dietary exposure of ochratoxin A in Central Anatolia Region, Turkey.

Authors:  Ayca Kulahi; Bulent Kabak
Journal:  Mycotoxin Res       Date:  2020-07-03       Impact factor: 3.833

3.  Ochratoxin A is not detectable in renal and testicular tumours.

Authors:  Nader Fahmy; Mark Woo; Mona Alameldin; Kyle Macdonald; Lee W Goneau; Peter Cadieux; Stephen E Pautler
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

4.  Preliminary results on Ochratoxin A concentrations in blood of patients with various kidney diseases in Germany.

Authors:  G Schwerdt; C Schuster; S Silbernagl; M Gareis; M Gekle
Journal:  Mycotoxin Res       Date:  2001-06       Impact factor: 3.833

5.  Ochratoxin A in human blood serum - retrospective long-term data.

Authors:  Erwin Märtlbauer; Ewald Usleber; Richard Dietrich; Elisabeth Schneider
Journal:  Mycotoxin Res       Date:  2009-09-15       Impact factor: 3.833

6.  The level of ochratoxin a in patients after nephrectomy.

Authors:  J Grajewski; P Jarzemski; M Twaruzek; K Kuzminska; M Trepala
Journal:  Mycotoxin Res       Date:  2007-03       Impact factor: 3.833

Review 7.  Ochratoxin A and human health risk: a review of the evidence.

Authors:  Travis R Bui-Klimke; Felicia Wu
Journal:  Crit Rev Food Sci Nutr       Date:  2015       Impact factor: 11.176

Review 8.  Role of exposure analysis in solving the mystery of Balkan endemic nephropathy.

Authors:  David T Long; Thomas C Voice
Journal:  Croat Med J       Date:  2007-06       Impact factor: 1.351

9.  Ochratoxin A and β2-microglobulin in BEN patients and controls.

Authors:  Pavlina Yordanova; Karmaus Wilfried; Svetla Tsolova; Plamen Dimitrov
Journal:  Toxins (Basel)       Date:  2010-04-20       Impact factor: 4.546

10.  Mycotoxins' activity at toxic and sub-toxic concentrations: differential cytotoxic and genotoxic effects of single and combined administration of sterigmatocystin, ochratoxin A and citrinin on the hepatocellular cancer cell line Hep3B.

Authors:  Nikolia Anninou; Ekaterini Chatzaki; Fotini Papachristou; Muichail Pitiakoudis; Constantinos Simopoulos
Journal:  Int J Environ Res Public Health       Date:  2014-02-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.